William Bordelon
Urology · Amarillo, TXNPI 1962483735
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Cipla USA Inc. at 38.6% of the total. Reporting peaked in 2020 at $1,727 and has fallen 98.6% since, to $25 in 2022. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.
Across 129 payments — averaging $26.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cipla USA Inc.$1K
- Astellas Pharma US Inc$912
- AbbVie$246
- Dendreon Pharmaceuticals LLC$175
- Sanofi$120
- Johnson & Johnson$80
- plus $537 from 16 others
What the payments were for
- Food & beverage$3,372100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cipla USA Inc. | 1 | $1,302 |
| Astellas Pharma US Inc | 61 | $912 |
| AbbVie(2 entities) | 15 | $246 |
| Dendreon Pharmaceuticals LLC | 8 | $175 |
| Sanofi | 4 | $120 |
| Johnson & Johnson | 6 | $80 |
| Amgen | 3 | $67 |
| Boston Scientific | 4 | $64 |
| Urovant Sciences Inc | 3 | $47 |
| Pfizer | 4 | $47 |
| Myriad Genetic Laboratories, Inc. | 3 | $42 |
| 180 Medical, Inc. | 2 | $41 |
| Tolmar Pharmaceuticals, Inc. | 3 | $39 |
| Neotract Inc. | 2 | $38 |
| Bayer | 2 | $32 |
| Blue Earth Diagnostics | 2 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Myovant Sciences Inc. | 1 | $12 |
| Duchesnay USA Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEMDRI (PLAZOMICIN)$1,302
How this compares
$3,372 in reported general payments places this provider in the 45th percentile of 878 urology providers in Texas.
Other urology in Amarillo
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
- Donald GriffithHouston$732K
- Michael TrotterAustin$590K
- Vitaly MargulisDallas$555K
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
- Jonathan Clavell HernandezHouston$500K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.